Presentation Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin Presenter: S. Lee July 11, 2012 REGISTER for free or LOG IN to view this content Policy & Practice Prevention CAD Pharma Clinical Pharma Coronary Stroke Factoid Up Next Presentation Systematic Review and Cost-Benefit Analysis of Radial Artery Access for Coronary Angiography Presenter: Matthew D. Mitchell July 12, 2012 More slides + Presentation Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES Presenter: Ryota Sakurai July 12, 2012 Presentation Comparison of Results of CABG vs. PCI in Octogenarians Presenter: 84194|Julian Gunn July 13, 2012 We Recommend
Presentation Systematic Review and Cost-Benefit Analysis of Radial Artery Access for Coronary Angiography Presenter: Matthew D. Mitchell July 12, 2012
Presentation Cilostazol Added to Aspirin and Clopidogrel Reduces Revascularization Without Increases in Major Adverse Events in Patients With DES Presenter: Ryota Sakurai July 12, 2012
Presentation Comparison of Results of CABG vs. PCI in Octogenarians Presenter: 84194|Julian Gunn July 13, 2012